TE_30

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MIR1_Amn
TE superfamily L2-end
TE class SINE
Gene NADK
Class Chimeric
Coding Non-coding, Other
Tumor-specific score 1.01
Counts of samples TCGA_tumor:57; TCGA_normal:2; GTEx:62
TSS chr1(-):1782106



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_30.1 NADK Chimeric Non-coding Non-coding chr1(-):1779176,1779196,1779905,1780029,1781756,1782107
teRNA_30.2 NADK Chimeric Other MEMEQEKMTMNKELSPDAAAYCCSACHGDETWSYNHPIRGRAKSRSLSASPALGSTKEFRRTRSLHGPCPVTTFGPKACVLQNPQTIIATPLSLASQLLPSPAVSHSGQGGVTGQVHVLPQPSDQGVLSGPRAARGQTAPQEEAVTQEEVEALVCGHTQRWVPGPVYDAAAGGSGWAQLSLRAGMGVGQATGHIQDPASQRLTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEARGAGGKGAWGAHGVGGASIHITAPRVGSAGGMSRLALCFQENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGENGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTS chr1(-):1753040,1753060,1753567,1753649,1754051,1754208,1754284,1754383,1754544,1754698,1755374,1755476,1756258,1756343,1756503,1756657,1757107,1757310,1759101,1759243,1759734,1759902,1761952,1762035,1765228,1765446,1779905,1779971,1781756,1782107
teRNA_30.3 NADK Chimeric Non-coding Non-coding chr1(-):1756323,1756343,1756503,1756608,1757181,1757310,1761952,1762035,1765228,1765446,1779905,1779971,1781756,1782107
teRNA_30.4 NADK Chimeric Non-coding Non-coding chr1(-):1779176,1779196,1779905,1779971,1781756,1782107
teRNA_30.5 NADK Chimeric Other MEMEQEKMTMNKELSPDAAAYCCSACHGDETWSYNHPIRGRAKSRSLSASPALGSTKEFRRTRSLHGPCPVTTFGPKACVLQNPQTIIATPLSLASQLLPSPAVSHSGQGGVTGQVHVLPQPSDQGVLSGPRAARGQTAPQEEAVTQEEVEALVCGHTQRWVPGPVYDAAAGGSGWAQLSLRAGMGVGQATGHIQDPASQRLTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEARGAGGKGAWGAHGVGGASIHITAPRVGSAGGMSRLALCFQENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGENGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTS chr1(-):1753040,1753060,1753567,1753649,1754051,1754208,1754284,1754383,1754544,1754698,1755374,1755476,1756258,1756343,1756503,1756657,1757107,1757310,1759101,1759243,1759734,1759902,1761952,1762035,1765228,1765446,1779905,1779967,1781756,1782107
teRNA_30.6 NADK Chimeric Non-coding Non-coding chr1(-):1756323,1756343,1756503,1756608,1757181,1757310,1761952,1762035,1765228,1765446,1779905,1779967,1781756,1782107
teRNA_30.7 NADK Chimeric Non-coding Non-coding chr1(-):1779176,1779196,1779905,1779967,1781756,1782107


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).